James Paul Lang insider trades

Open-market stock purchases and sales by James Paul Lang, Director at OptimizeRx Corp, from SEC Form 4 filings since Dec 8, 2016.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -51%.

Recent trades

DateStockTradeValue
Jun 9, 2026OPRX OptimizeRx CorpBought (not open market)—
May 5, 2026HALO Halozyme Therapeutics, IncBought (not open market)—
May 5, 2026HALO Halozyme Therapeutics, IncBought (not open market)—
Jan 5, 2026BIVI Biovie IncBought (not open market)—
Jan 5, 2026BIVI Biovie IncBought (not open market)—
Jan 2, 2026HALO Halozyme Therapeutics, IncBought (not open market)—
Jan 2, 2026HALO Halozyme Therapeutics, IncBought (not open market)—

Companies traded

  • OPRX OptimizeRx Corp: 2 buys, last Jun 9, 2026
  • HALO Halozyme Therapeutics, Inc: other filings, last May 5, 2026
  • BIVI Biovie Inc: other filings, last Jan 5, 2026

Get free alerts when James Paul Lang files a new trade →